Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 5.2.2020KRKA, d.d., Novo mesto (KRK-2)79137Elicea 10 mg (tbl flm 60x10 mg (blis. OPA/Al/PVC/Al))23.3.2020R
 5.2.2020KRKA, d.d., Novo mesto (KRK-2)89864Escepran 25 mg filmom obalené tablety (tbl flm 30x25 mg (blis.PVC/PVDC/Al))9.3.2020R
 5.2.2020KRKA, d.d., Novo mesto (KRK-2)90145Lorista 50 (tbl flm 84x50 mg)23.3.2020R
 4.2.2020G.L. Pharma GmbH (GLH-2)7853AMemolan 10 mg filmom obalené tablety (tbl flm 30x10 mg (blis.PVC/PE/PVDC/Al))4.2.2020O
 4.2.2020G.L. Pharma GmbH (GLH-2)7866AMemolan 20 mg filmom obalené tablety (tbl flm 30x20 mg (blis.PVC/PE/PVDC/Al))4.2.2020O
 4.2.2020G.L. Pharma GmbH (GLH-2)9462CEslibon 800 mg tablety (tbl 30x800 mg (blis.PVC/Al-transparent.))4.2.2020O
 4.2.2020Viatris Limited (VIM)5804CSeizpat 150 mg (tbl flm 56x150 mg (blis.PVC/PVDC/Al))5.2.2020O
 4.2.2020Viatris Healthcare Limited (VIM-1)26443Fevarin 100 (tbl flm 30x100 mg (blis.PVC/PVDC/Al))10.2.2020R
 4.2.2020Mylan IRE Healthcare Limited (MYR)7022ACholib 145 mg/40 mg filmom obalené tablety (tbl flm 30x145 mg/40 mg (blis.Al/Al))10.2.2020R
 4.2.2020B.Braun Melsungen AG (BME)13902Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x500 ml (fľ.PE))4.2.2020O
 4.2.2020B.Braun Melsungen AG (BME)5716ARingerfundin (sol inf 10x500 ml (fľ.PE))4.2.2020O
 4.2.2020AXONIA, a.s. (AXO)3596BVitamin D3 Axonia 30 000 IU filmom obalené tablety (tbl flm 1x30000 IU (blis.PVC/PVDC/Al))10.2.2020O
 4.2.2020Zentiva a.s. (ZNT-SK-2)70425Rhefluin (tbl 30x5,68 mg/50 mg (blis. Al/PVC))4.2.2020O
 4.2.2020Berlin-Chemie AG (BCE)84093Corvitol 50 (tbl 50x50 mg (blis.Al/PVC))6.2.2020O
 4.2.2020Upjohn EESV (UPO-NL)34353SORTIS 80 mg (tbl flm 100x80 mg (blis.PA/Al/PVC))5.2.2020R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)